What is NMN?
Nicotinamide mononucleotide (NMN) is a small molecule your body uses to build NAD+ (nicotinamide adenine dinucleotide, the coenzyme every cell needs to run its metabolism). NAD+ levels drop as you get older. That single fact grew into a whole supplement trend.
The pitch is simple. Top up NAD+ from the outside, and you slow down some parts of aging. Harvard's David Sinclair is the loudest voice behind it. The human evidence is still thin. A small 2021 trial in Science (Yoshino) gave 250 mg of NMN a day for 10 weeks to postmenopausal women with prediabetes and overweight or obesity. Their muscle insulin sensitivity improved [5]. A 2022 study in npj Aging (Igarashi) found that 250 mg a day raised blood NAD+ in older men. Gait speed and left-hand grip improved only nominally, and the authors say that needs checking in larger studies [6]. That is mechanism evidence. It does not show a longer life.
Want the science of NMN? See our longevity supplements guide. This guide is only about the legal picture in Germany and the EU. No dosing advice, only the EU safety limit. Not where to buy. Not medical use. The goal here is to help you read a confusing rulebook before you spend money on something that may not be legal to sell where you live.
Is NMN banned in the EU? (status September 2026)
Short answer: yes, for now. NMN is a novel food without EU authorisation, so it may not be sold as food or a food supplement anywhere in the EU [1]. One product is close. On 11 May 2026 EFSA published a positive safety opinion on EffePharm's NMN, which the company markets as Uthever® [7]. As of late September 2026, the European Commission has not adopted the authorisation yet.
The EU Novel Food regulation (Regulation (EU) 2015/2283) decides which ingredients can be sold as food or supplements anywhere in the EU [1]. An ingredient counts as "novel" if Europeans did not eat it in any meaningful amount before 15 May 1997. Anything novel needs authorisation before it can legally hit shelves.
Where NMN actually stands:
- The EU novel food catalogue lists NMN as a novel food. It needs authorisation before it can be sold legally as a supplement anywhere in the bloc.
- On 11 May 2026, EFSA published a positive safety opinion on EffePharm's NMN. The verdict: up to 300 mg per day is safe for adults, excluding pregnant and breastfeeding women [7].
- The safety verdict has limits. In a 90-day rat study, the highest dose caused changes in reproductive organs. The highest dose without adverse effects was 400 mg per kg of body weight a day. EFSA judged that margin sufficient for 300 mg a day in adults. Higher intakes were not assessed [7].
- The European Commission and the Member States still have to adopt the actual authorisation. The Commission has seven months from the EFSA opinion to put a draft authorisation to the Member States, so until about December 2026 [1]. Their vote and publication can take longer. When it lands, the authorisation will be product-specific to EffePharm. So generic NMN from other producers stays under Novel Food restrictions until each applicant earns its own positive opinion and Commission authorisation.
Other countries:
- USA: The FDA pulled NMN from the dietary supplement category in late 2022, because of a parallel pharmaceutical filing for the same molecule. Then citizen petitions came in from the Natural Products Association and the Alliance for Natural Health. On 29 September 2025 the FDA issued a response letter that set aside its 2022 superseding letter and put NMN back inside the dietary supplement definition [4]. A regulatory reversal, not a court ruling.
- Japan and parts of Asia: NMN is widely available and openly sold.
- Switzerland: Outside the EU, so its own rules apply.
What this means at the till. Products marketed in Germany as "NMN supplements" are sold without the authorisation EU food law requires [1]. Many shops label NMN as "laboratory chemical" or "for research use only." That label does not turn it into an authorised food. It only means nobody has cleared it for you to swallow.
The German-speaking market (DACH: Germany, Austria, Switzerland) in practice. Some online shops in these countries sell NMN anyway. Many products ship from outside the EU, often from China, where EffePharm, the company behind the EFSA opinion above, is based.
Regional status table (September 2026):
| Region | Supplement status | Rx / medicine | Customs / import |
|---|---|---|---|
| Germany | Not authorised, so sale as food is not allowed; EFSA positive safety opinion on EffePharm's NMN published 11 May 2026, Commission authorisation pending and product-specific [1, 7] | Not approved | EU-internal: no issue |
| Austria | Same as Germany (EU rules apply) | Not approved | EU-internal: no issue |
| Switzerland | Outside EU Novel Food regime; Swissmedic and BLV have their own process | Swissmedic regulates medicines | Check current BLV status before ordering |
| USA | Lawful as dietary supplement since 29 Sept 2025 FDA amendment | Not approved as drug | Ships freely within US |
| China | Not approved as food or health food on the mainland. NHC, China's health regulator, rejected NMN as a food additive in May 2023. It is not approved as a new food raw material either. Several cross-border e-commerce platforms stopped selling imported NMN in 2024. China is still a major NMN producer and exporter | N/A | Customs interception possible for EU buyers |
| Japan | Widely sold, openly marketed | Not approved as drug | Legal export; EU import still bound by EU Novel Food rules |
Can you still buy NMN in Germany?
In practice, you can still find NMN online in Germany. But no shop may sell it as food, no doctor can prescribe it, quality is unverified, and any concrete health claim is illegal. Most of it is labelled "laboratory chemical," so the full responsibility for sourcing and safety lands on you. Four things are worth knowing before you order.
1. It is sold online anyway. NMN turns up on German and EU shops. It's usually labelled "laboratory chemical" or "research use only" to keep regulators at arm's length. Some shops in Germany, Austria and Switzerland offer it. Much of the stock comes from non-EU countries, often China. That is also where EffePharm sits, the company behind the EFSA application. Amazon has yanked NMN from its German marketplace and quietly put it back several times, depending on the legal read of the month.
2. A doctor cannot really prescribe it. NMN is not an approved medicine in Germany. So doctors cannot write the normal pink prescription (the Kassenrezept used for public health insurance) for it. Some private longevity clinics offer NAD+ infusions (a different substance in a different regulatory bucket) or point patients toward international suppliers. But the legal responsibility for what you put in your body lands squarely on you.
3. Quality and labelling are a coin flip. In a grey market, nobody is closely checking purity or labels. Independent tests by ConsumerLab.com have repeatedly found that the actual NMN inside the capsule can differ sharply from what the bottle promises on the front.
4. EU Health Claims Regulation (plus HWG). For a food supplement, the rule that bans slogans like "NMN rejuvenates cells" or "NMN extends life" is the EU Health Claims Regulation (Regulation (EC) No 1924/2006, called HCVO in Germany) [12]. It only allows health claims that are scientifically proven and on the EU's authorised list. Germany's Heilmittelwerbegesetz (HWG), the law on advertising medicines and treatments, stacks on top when the claim crosses into medicinal territory (for example "NMN prevents Alzheimer's") [3]. That is exactly why German sellers keep their product copy deliberately vague.
What about NR, niacinamide, and NAD+?
The legal alternative is nicotinamide riboside (NR), an NAD+ precursor that the EU authorised as a novel food in 2020, so it is sold legally in Germany [2]. Niacin and niacinamide (vitamin B3) are long approved and cheap, while NAD+ IV drips are a medical service only a doctor or Heilpraktiker may deliver. Each option carries a different legal status and evidence base.
| NMN | NR (nicotinamide riboside) | Niacin / niacinamide (B3) | NAD+ IV drip | |
|---|---|---|---|---|
| EU status (September 2026) | Not authorised; EFSA positive in May 2026, Commission decision pending [7] | Authorised novel food since 2020 [2] | Long authorised vitamin | Medical service, not a food |
| EU daily limit in supplements | None yet; EFSA judged 300 mg safe for adults [7] | 300 mg for adults [2] | National limits, no EU-wide cap | Not applicable |
| Raises blood NAD+ in humans | Yes [5, 6] | Yes [8, 9] | Yes, less targeted | Yes, but evidence for lasting effects is thin |
| Hard longevity outcomes in humans | None | None | None | None |
Nicotinamide riboside (NR). Another NAD+ precursor, and the easier of the two to discuss in public. The EU authorised NR as a novel food in 2020 under Commission Implementing Regulation 2020/16, which makes it legally sold in Germany [2]. The human trial record on NR is somewhat broader than the one on NMN. A 2016 study (Trammell) showed that NR doses up to 1,000 mg raise blood NAD+ in healthy adults [8]. A 2018 crossover trial in healthy middle-aged and older adults (Martens) gave 500 mg of NR twice daily for 6 weeks. It was well tolerated and raised NAD+. In a small exploratory subgroup with elevated or stage-1 blood pressure (n=13), systolic pressure was about 9 mmHg lower. That signal was not statistically significant. Treat it as a hypothesis to test, not a confirmed effect [9]. But a 2018 trial (Dollerup) was negative: 1,000 mg twice daily for 12 weeks did not improve insulin sensitivity in obese, insulin-resistant men [10]. So NAD+ goes up reliably. Whether that buys you years of healthspan is still wide open.
Where NMN and NR both stand. Both reliably raise NAD+ in blood. Neither has a large outcome trial. Most of the rejuvenation evidence comes from rodents or cell lines, some of them cancer cell lines, which is exactly where you do not want to push pro-growth signals. A 2024 study in Nature Medicine (Ferrell) adds one more caveat. High NAD+ turnover can raise 2PY and 4PY, two breakdown products left when the body clears excess vitamin B3. In observational data, both were linked to higher cardiovascular risk [11]. That is an association, not proof of harm. Caution is warranted with long-term mega-doses. NMN and NR are also broken down to nicotinamide in the end, so the caveat may apply to all NAD+ precursors at high doses. Still worth knowing before you commit a year of capsules to either molecule.
Niacin and niacinamide (vitamin B3). The original NAD+ building blocks. Long approved, and very cheap. Niacin causes the classic warm facial flush, and niacinamide does not. But both raise NAD+ less selectively than NR or NMN.
NAD+ IV drips. Some private clinics and Heilpraktiker offering longevity services provide NAD+ through a drip. Because it counts as a medical service, in Germany it must be delivered by a licensed doctor or a qualified Heilpraktiker under specific conditions. Evidence for lasting effects is thin, and sessions are expensive (usually 200 to 500 euros each).
Lifestyle levers that raise NAD+: exercise, eating fewer calories, and good sleep. All three are well supported by research. And they sit outside every regulatory question you might have.
How to spot a trustworthy NMN product
Before buying NMN, check six things. Where is the maker based? Is there an independent certificate of analysis showing ≥98% purity? How is the product labelled? What does a longevity-trained doctor advise? Are the promised effects realistic? And do you have a cancer history? Overblown longevity or disease claims are a quality red flag. They are also likely illegal under EU rules [12].
1. Where is the maker based? EU makers follow EU law. US and Asian makers do not. So if something goes wrong, recalls, liability, and quality control are much harder to enforce on products shipped from outside the bloc.
2. Is there an independent certificate of analysis (COA)? A serious maker is happy to hand over a COA from an independent lab. It should confirm both purity and actual NMN content, ideally by HPLC or qNMR.
3. How is the product labelled? "Dietary supplement" means the seller is using the regulated food channel. For NMN without novel food authorisation, that is not allowed [1]. "Research use only" or "not for human consumption" means the seller is sidestepping food law, and the responsibility shifts entirely to you.
4. What does your doctor say? For NAD+ questions, a doctor trained in preventive or functional medicine is usually a better sounding board than a general GP without that background. These practices are showing up in bigger German cities, mostly on a self-pay longevity basis.
5. Are the promised effects realistic? Serious sources talk about NAD+ levels and mechanisms. So if a product or seller promises concrete longevity, rejuvenation, or disease prevention, that likely breaches the EU Health Claims Regulation [12] (and the HWG if it is framed as medical treatment [3]). It's also a red flag about how careful the seller actually is.
6. A caution on cancer. If you have an active or recently treated cancer, caution is warranted here. Lab work on cancer cell lines points one way. NAMPT, the enzyme cells use to recycle NAD+, feeds the SASP (senescence-associated secretory phenotype): the inflammatory signals that worn-out, senescent cells release. In some tumour models, NAD+ metabolism also supports tumour metabolism. That is cell-line and mouse data, not proof of harm in humans. But it is enough for a caveat: use NMN or NR in cancer only in coordination with your oncology team.
What to look for on a NMN COA (Certificate of Analysis):
- Batch / Lot number (matches the bottle you received)
- Assay method: HPLC (liquid chromatography, which separates and measures each compound) or qNMR (quantitative NMR spectroscopy) preferred
- Purity: ≥98% is the accepted bar
- Heavy metals panel: lead (Pb), arsenic (As), cadmium (Cd), mercury (Hg), all below USP limits (the US Pharmacopeia standard)
- Microbial counts: within food-grade limits
- Endotoxin (toxins from bacterial cell walls): optional for oral; required if injectable/IV
- Third-party lab name: not the manufacturer's own in-house lab
Linked resources. For the NAD+ booster science and the dose ranges used in trials (NMN and NR side by side), see the NAD+ boosters section of the longevity supplements guide. Those doses come from US and Asian trials, not from EU-authorised products.
Frequently asked questions
Is NMN legal in Germany?
Why is NMN banned in Europe?
Can I buy NMN at a pharmacy, dm or on Amazon?
Can my doctor prescribe NMN?
What's the difference between NMN and NR?
Does NMN actually work?
How much NMN per day is considered safe?
Is NMN dangerous or linked to cancer?
Will NMN be approved in the EU soon?
Sources
- European Parliament and Council. (2015). Regulation (EU) 2015/2283 on novel foods
- European Commission. (2020). Commission Implementing Regulation (EU) 2020/16 authorising nicotinamide riboside chloride as a novel food
- Bundesministerium der Justiz / Bundesamt für Justiz. (2024). Heilmittelwerbegesetz (HWG)
- US Food and Drug Administration. (2025). Response Letter from FDA HFP to Natural Products Association and Alliance for Natural Health USA (Citizen Petition, Docket FDA-2023-P-0872)
- Yoshino M, Yoshino J, Kayser BD, et al. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Sciencedoi:10.1126/science.abe9985
- Igarashi M, Nakagawa-Nagahama Y, Miura M, et al. (2022). Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. npj Agingdoi:10.1038/s41514-022-00084-z
- EFSA NDA Panel (Turck D, Bohn T, et al.). (2026). Safety of beta-nicotinamide mononucleotide (β-NMN) pursuant the regulation (EU) 2015/2283 and the bioavailability of nicotinamide from this source in the context of Directive 2002/46/EC. EFSA Journal 24(5)doi:10.2903/j.efsa.2026.10007
- Trammell SAJ, Schmidt MS, Weidemann BJ, et al. (2016). Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nature Communicationsdoi:10.1038/ncomms12948
- Martens CR, Denman BA, Mazzo MR, et al. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communicationsdoi:10.1038/s41467-018-03421-7
- Dollerup OL, Christensen B, Svart M, et al. (2018). A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. American Journal of Clinical Nutritiondoi:10.1093/ajcn/nqy132
- Ferrell M, Wang Z, Anderson JT, et al. (2024). A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk. Nature Medicinedoi:10.1038/s41591-023-02793-8
- European Parliament and Council. (2006). Regulation (EC) No 1924/2006 on nutrition and health claims made on foods
Questions about longevity rules?
Our local chapters often sit down with doctors, pharmacists, and lawyers to talk through the legal and practical side of longevity products. Join an event near you.
Events near meExperts in this field
Speakers from the Longevity Switzerland community on this topic
Related guides
Biological vs chronological age
Why your biological age matters more than your birthday
How to slow aging naturally
Evidence-based lifestyle interventions that actually work
Longevity supplements
What the science really says about NMN, Vitamin D, Omega-3, and more.
Peptides: An honest guide
What peptides are, how the field got from insulin to Ozempic, the IGF-1 paradox, the real risks, and the legal status in Germany, Austria, and Switzerland.
Created by Maurice Lichtenberg, Founder, Longevity Cities
The information provided here is for educational purposes only. Longevity Switzerland does not provide medical advice, diagnosis, or treatment. Always seek the advice of qualified healthcare providers with questions regarding medical conditions.
